The Hospital Universitario Puerta de Hierro-Majadahonda (HUPHM) was founded in 1964. In October 2009, it moved to a new 65.000 m2 building located in Majadahonda and three-times the size of the former hospital. Today, HUPHM provides outpatient and inpatient care at several sites in the north of Madrid serving a population ~ 550.000 people.
During 2013, the Medical Oncology Service attended 1,505 new outpatients and performed 15,939 follow-ups. The service has a 20 beds hospitalisation ward together with 10 outpatients consulting rooms, a day hospital, privates offices for doctors as well as clinical research laboratories.
The Phase I Clinical Oncology Unit (ONCO-FI) HUPHM receives about 25,000 admissions annually, more than 150,000 patients are treated by the emergency services, more than 56,000 outpatients are seen and more than 200 types of transplants are performed.
There are medical and nursing students (both pre- and post-graduate) and the hospital also hosts the Puerta de Hierro Medical Research Institute (IDIPHIM) with a 3200 m2 dedicated investigation area.
There are 552 doctors, 1767 nurses and other related health care professionals, and 293 fellows in differents specialities. There are 613 beds, an operating area with 22 operating rooms, 52 beds in medico-surgical intensive care unit and a medical-surgical ambulatory clinic with 60 beds.
Areas of specialisation
The hospital specialises in the research and treatment of all types of cancer. The hospital's Medical Oncology Service provides continuity of care to cancer patients so that they continuously receive regular follow-ups after being discharged from hospital.
Palliative and supportive care
The Palliative Care Unit (PCU) is integrated within a Community palliative care network which includes Palliative Care Units in other hospitals, with teams that provide home palliative care as well as specific centres for palliative care patients.
This network is coordinated through fortnightly follow-up meetings in order to maintain continuity of patient care. In the case of terminally ill patients, when no benefit can be obtained from anti-tumoral interventions, quality of life is the cornerstone of the Palliative Care Unit. In these cases, patient follow-up is carried out by the Palliative Care Unit with support from the oncologist responsible for the patient's oncological treatment together with the palliative care home support team.
This continuity of care philosophy is shared by all the members of the team. For this reason, there is a close relationship between the members of this network in order to offer optimal care during the final stages of the patient's life so as to be able to provide the best quality of life in the best place. Whenever required, the PCU is able to provide care in the patient's home or in specialised palliative care centres.